Literature DB >> 387690

Failure of central axonal regeneration after immunosuppressive treatment.

M Berry, A C Riches, J Knowles, P Willis, D Steers.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 387690      PMCID: PMC1233043     

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


× No keyword cloud information.
  57 in total

1.  TREATMENT OF MULTIPLE SCLEROSIS WITH TRANYLCYPROMINE.

Authors:  N KOMESAROFF
Journal:  Lancet       Date:  1964-12-26       Impact factor: 79.321

2.  AXON REGENERATION IN THE RAT SPINAL CORD.

Authors:  W J O'CALLAGHAN; T J SPEAKMAN
Journal:  Surg Forum       Date:  1963

3.  Effect of trans-2-phenylcycloproplylamine upon norepinephrine concentration and monamine oxidase activity of rat brain.

Authors:  H GREEN; R W ERICKSON
Journal:  J Pharmacol Exp Ther       Date:  1960-07       Impact factor: 4.030

4.  Postnatal development of the cerebral cortex in the rat.

Authors:  J T EAYRS; B GOODHEAD
Journal:  J Anat       Date:  1959-10       Impact factor: 2.610

5.  Biochemical findings relating to the action of serotonin.

Authors:  S UDENFRIEND; H WEISSBACH; D F BOGDANSKI
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

6.  Increase in tissue serotonin following administration of its precursor 5-hydroxytryptophan.

Authors:  S UDENFRIEND; H WEISSBACH; D F BOGDANSKI
Journal:  J Biol Chem       Date:  1957-02       Impact factor: 5.157

7.  The pyretogenic effect of 5-hydroxytryptophan and its comparison with that of ISD.

Authors:  A HORITA; J H GOGERTY
Journal:  J Pharmacol Exp Ther       Date:  1958-02       Impact factor: 4.030

8.  A urea silver nitrate method for nerve fibers and nerve endings.

Authors:  L H UNGEWITTER
Journal:  Stain Technol       Date:  1951-04

9.  Studies on cell-mediated hypersensitivity to neural antigens after experimental spinal cord injury.

Authors:  D O Willenborg; E A Staten; E Eidelberg
Journal:  Exp Neurol       Date:  1977-02       Impact factor: 5.330

10.  The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors:  B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.